Literature DB >> 3814619

Isolation and characterization of an induced chondroitinase ABC from Flavobacterium heparinum.

Y M Michelacci, D S Horton, C A Población.   

Abstract

During the investigation of alternative methods for the large scale preparation of chondroitinases AC, B and C from Flavobacterium heparinum, a new chondroitinase activity was observed. This new enzyme, like the other chondroitinases, acts as an eliminase, forming unsaturated sulfated disaccharides from dermatan and chondroitin sulfates. In contrast to the chondroitinases previously described, which are endoglycosidases, this chondroitinase ABC cleaves the glycosidic linkages in an exolytic fashion, beginning at the reducing end of the substrate molecules. The oligosaccharides formed as transient products by the action of either chondroitinases or testicular hyaluronidase upon dermatan and chondroitin sulfates are also rapidly degraded by the chondroitinase ABC, regardless of their size or the presence of delta-4,5 unsaturation in the terminal uronic acid residue. The maximum activity of the chondroitinase ABC occurs at 30 degrees C and at pH 6.0-7.5. Only 15% of the activity was observed at 37 degrees C, indicating that the enzyme is very sensitive to thermal denaturation. It is strongly inhibited by phosphate ions and is also inhibited by the unsaturated disaccharides formed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3814619     DOI: 10.1016/0304-4165(87)90016-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  2 in total

1.  Cloning and expression in Escherichia coli of the gene encoding the Proteus vulgaris chondroitin ABC lyase.

Authors:  N Sato; M Shimada; H Nakajima; H Oda; S Kimura
Journal:  Appl Microbiol Biotechnol       Date:  1994-03       Impact factor: 4.813

2.  Crosstalk between tumor cells and lymphocytes modulates heparanase expression.

Authors:  Thérèse Rachell Theodoro; Leandro Luongo Matos; Renan Pelluzzi Cavalheiro; Giselle Zenker Justo; Helena Bonciani Nader; Maria Aparecida Silva Pinhal
Journal:  J Transl Med       Date:  2019-03-29       Impact factor: 5.531

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.